Cervical cytology: evaluation and management of abnormalities. ACOG technical bulletin number 183--August 1993.
As a result of rapidly evolving technology, advances in the understanding of the pathogenesis of cervical neoplasia, and the introduction of TBS terminology, we stand at a crossroads in the screening and management of this disease. This bulletin reflects management considered appropriate at this time. A number of key issues as indicated above must be addressed before more specific guidelines can be incorporated into routine clinical practice. Until data from clinical trials evaluating these new methods are available, the gynecologist is best advised to manage patients using the guidelines in this Technical Bulletin.
D002278:Carcinoma in Situ / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D002584:Cervix Uteri / Q000473:pathology*; D005260:Female; D006801:Humans; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D014626:Vaginal Smears